Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

11.88
Delayed Data
As of Mar 31
 +0.01 / +0.08%
Today’s Change
4.13
Today|||52-Week Range
12.50
+5.13%
Year-to-Date

Today’s Trading

Previous close11.87
Today’s open11.75
Day’s range11.67 - 12.00
Volume1,180,963
Average volume (3 months)1,522,258
Market cap$1.3B
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-24.17%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-0.83-1.63%
FWPForward Pharma A/S-0.09-0.32%
ZIOPZIOPHARM Oncology In...-0.84-7.24%
CLLSCellectis SA-0.62-1.76%
Data as of 03/31/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account